Pharmacovigilance Market by Methods (Cohort Event Monitoring, Intensified ADRS Reporting, Spontaneous Reporting, Targeted Spontaneous Reporting and EHRs Mining), Service Types (Contact or Outsourcing and In-House), and Pipeline Analysis of Clinical Phases 1, 2, 3 and 4 (Post Marketing Surveillance) and Forecast 2017-2021

Pharmacovigilance Market by Methods (Cohort Event Monitoring, Intensified ADRS Reporting, Spontaneous Reporting, Targeted Spontaneous Reporting and EHRs Mining), Service Types (Contact or Outsourcing and In-House), and Pipeline Analysis of Clinical Phases 1, 2, 3 and 4 (Post Marketing Surveillance) and Forecast 2017-2021

Pharmacovigilance (PV or PhV), also known as drug safety, is science and activities relating to the collection, detection, assessment, understanding, monitoring, and prevention of adverse effects or any other drug-related problem.  Pharmacovigilance activities are performed across all phases of drug development, including preclinical studies, phase I to phase III trials, and phase IV or post market surveillance stages. Information received from patients and healthcare providers, as well as other sources such as the medical literature, plays a critical role in providing the data necessary for Pharmacovigilance. It is more concerned with identifying the hazards associated with pharmaceutical products and with minimizing the risk of any harm that may come to patients.

The global Pharmacovigilance market report estimates the market size (Revenue USD million – 2014 to 2021) for key market segments based on the methods (cohort event monitoring, intensified ADRs reporting, spontaneous reporting, targeted spontaneous reporting and EHRs mining), service types (contact or outsourcing and in-house), pipeline analysis of clinical phases 1, 2, 3 and 4 (post marketing surveillance), and forecasts growth trends (CAGR% – 2017 to 2021).

The global Pharmacovigilance market report also provides the detailed market landscape, market drivers, restraints, opportunities), market attractiveness analysis and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and services offered, and recent developments. The global Pharmacovigilance market research report is divided by geography (regional and country based) into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.

Major players operating in the global Pharmacovigilance market and included in this report are Accenture, Plc, Clinquest Group B.V., Cognizant Technology Solutions, Covance, Inc. ICON, Plc, iMED Global Corporation, inVentiv Health, Inc., Parexel International Corporation, Pharmaceutical Product Development LLC, PRA Health Sciences, Inc., Quintiles Transnational Holdings Inc, F. Hoffmann-La Roche Ltd., Sanofi, Synowledge LLC, Wipro Limited.

Category:
  1. Introduction
  2. Executive Summary
    • Market Size Estimation (Revenue USD Million, 2014-2021)
    • Forecast Estimation (Revenue USD Million and CAGR%, 2017-2021)
  3. Research Methodology
  4. Market Landscape
    • Market Dynamics
      • Drivers
      • Barriers
      • Opportunities
    • Market Share Analysis
      • Companies
      • Drugs
    • Market Trends Analysis
      • Key success factors
      • Market Growth Rate
    • Market Attractiveness Analysis
    • Market Profitability Analysis
      • Buyer power
      • Supplier power
      • Barriers to entry
      • Threat of substitute products
      • Rivalry among firms in the industry
    • Distribution Channels
  5. Market Segmentation [refer Market Segments and Companies Tab]
    • Drug Class or Drug (Brand) Type
    • Drug or Disorder Test
    • Indication Type
    • Drug Treatment
    • Mechanism of Action
    • Therapeutic Area or Nature of Application
    • End User Groups
  6. Geography (Region, Country)
    • North America (U.S., Canada)
    • Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
    • Latin America (Brazil, Mexico, Rest of LA)
    • Asia Pacific (Japan, China, India, Rest of APAC)
    • Rest of the World (Middle East & Africa)
  7. Regulatory Overview 
    • IND, NDA filed, FDA, EMEA Approvals
  8. Pipeline Analysis(Phase 1, 2 and 3 Drugs)
    • Phase 3 Drugs Forecast Estimation (Approval to 2025)
    • Phase 1 and 2 Drugs – Qualitative Analysis
  9. Company Profiles [refer Market Segments and Companies Tab]
    • Company Overview
    • Financial Snapshot (FY 2014-2016)
    • Product Portfolio
    • Business Strategies
    • Recent Developments
  10. Recommendations
  11. References

Pharmacovigilance Market

1. Method
1.1. Cohort Event Monitoring
1.2. Intensified Adverse Drug Reactions (ADRs) Reporting
1.3. Spontaneous Reporting
1.4. Targeted Spontaneous Reporting
1.5. Electronic Health Records (EHRs) Mining

2. Service Type
2.1. Contract or Outsourcing
2.2. In-house

3. Clinical Phase
3.1. Preclinical
3.2. Phase 1
3.3. Phase 2
3.4. Phase 3
3.5. Phase 4 (Post Marketing Surveillance)

4. Company Profiles
4.1. Accenture plc
4.2. Bristol-Myers Squibb
4.3. Clinquest Group B.V.
4.4. Cognizant Technology Solutions
4.5. Covance, Inc.
4.6. F. Hoffmann-La Roche Ltd.
4.7. GlaxoSmithKline plc.
4.8. ICON plc.
4.9. iGATE Corporation
4.10. iMEDGlobal Corporation
4.11. inVentiv Health, Inc.
4.12. Novartis AG
4.13. Parexel International Corporation
4.14. Pfizer, Inc.
4.15. Pharmaceutical Product Development, LLC.
4.16. PRA Health Sciences, Inc.
4.17. Quintiles Transnational Holdings, Inc.
4.18. Sanofi SA
4.19. Synowledge LLC
4.20. Wipro Ltd.

Request market specific full ToC and sample pages for this report

Full Name*

Email*

Phone Number* [Please add country code]

Subject*

Message*